TrialSpark, Inc.
Pharmaceutical company · New York, United States
TrialSpark, Inc. is a pharmaceutical company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $372 million sold in a notice filed in 2024.
Profile compiled from public records. Is this your company? Request a correction or update
TrialSpark at a glance
Typepharmaceutical company
HeadquartersNew York, United States
SEC CIK2028122
What does TrialSpark do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $372.2 million sold (2024).
Frequently asked questions about TrialSpark
Where is TrialSpark headquartered?
TrialSpark, Inc. is headquartered in New York, United States.
What does TrialSpark do?
TrialSpark, Inc. is a pharmaceutical company.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences